Drug intelligence / Profile preview

NiuBeiXiaoHe

Development stage
Preclinical
Lead developer
广东奇方药业
Modality
Small Molecules
Administration
Oral
01

Overview

NiuBeiXiaoHe (NBXH) is a traditional Chinese medicine (TCM) compound prescription used primarily for the treatment of tuberculosis (TB). It is an empirical formula composed of six main herbal ingredients, including Fritillaria cirrhosa, Bletilla striata, Houttuynia cordata, Platycodon grandiflorum, Fructus arctii, and glutinous rice. The formulation has demonstrated significant anti-tuberculous effects in both animal models and clinical practice. Mechanistically, NBXH exerts its effects by inhibiting the growth and proliferation of Mycobacterium tuberculosis through multiple pathways—such as modulating immune responses (including upregulation of chemokines like CXCL1-3/5/10 and cytokines such as IL-6 and TNF), enhancing autophagy and NK cell-mediated cytotoxicity, correcting abnormal gene expression induced by TB infection, reducing inflammatory damage in lung tissue, and restoring immune homeostasis. Network pharmacology studies have identified at least 26 active compounds in NBXH linked to 119 potential anti-TB targets across 41 KEGG pathways relevant to TB pathogenesis[1][2][3][4][5].

Brand names
NiuBeiXiaoHe
Other names
NBXH牛贝消合
02

Targets

Neuraminidase

Beyond the preview

Go deeper on NiuBeiXiaoHe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NiuBeiXiaoHe.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call